· rebuilt nightly from public records
Signal Sheet
Headquartered in Fort Lauderdale, Florida, Coeptis Therapeutics is a publicly listed finance services company, founded 2022. It raised $4M in Jul 2025 and its filings name 8 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | David Mehalick | SEC filing, Jul 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Brian Cogley | SEC filing, Jul 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Daniel Yerace | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Christopher Calise | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Christopher Cochran | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Tara Maria DeSilva | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Philippe Deschamps | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Gene Salkind | SEC filing, Jul 2025 | Technology and tooling decisions |
Officer or director change
New leadershipSigned a material agreement
Corporate eventEquity raise reported to the SEC, Jul 2025. Money arrives before the spending plan does.
CapitalThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Nov 3, 2026 | Officer or director change | New leadership | SEC filing |
| Sep 8, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Sep 8, 2026 | Completed an acquisition or sale | Corporate event | SEC filing |
| Aug 24, 2026 | Officer or director change | New leadership | SEC filing |
| Jul 29, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Jul 24, 2025 | Raised $4M in equity from 9 investors | Capital | SEC filing |
Lakewave finds the right people at Coeptis Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Coeptis Therapeutics with a free trial →| Headquarters | Fort Lauderdale, Florida, per the filing address |
| Industry group | Finance Services |
| Founded | 2022, DE |
| Ownership | Listed company |
| Raise history | $4M (Jul 2025) |
| Lakewave Rising | 40 · 2 kinds of evidence · rank in Florida after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Coeptis Therapeutics reported a $4M equity raise to the SEC on Jul 24, 2025 with 9 investors.
The company's SEC filing, Jul 2025 names David Mehalick (Executive Officer) among its officers.
Fort Lauderdale, Florida, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.